Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

In the recent past, we observed an increased risk of cancer in the population with human immunodeficiency virus (HIV) owing to the development of antiretroviral therapies that decreased mortality caused by HIV-specific infections. This particularly fragile population is frequently excluded from clin...

Full description

Saved in:
Bibliographic Details
Main Authors: Lise Bertin, MD, Anthony Canellas, MD, Baptiste Abbar, MD, Marianne Veyri, Jean-Philippe Spano, MD, PhD, Jacques Cadranel, MD, PhD, Armelle Lavolé, MD
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
HIV
Online Access:https://doaj.org/article/ec6f4644ae4240f5bb7de65702a720dc
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items